MDGL
MADRIGAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$400.43
+1.04%Margins
Gross margin
91.0%
EBITDA margin
-8.5%
EBIT margin
-10.7%
Net margin
-10.9%
FCF margin
-11.8%
-24.8%
Return on equity
-10.8%
Return on assets
-15.6%
Return on invested capital
1.07x
Asset turnover
-$157.0M
Cash from operations
$41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026